1. Home
  2. INKT vs ACXP Comparison

INKT vs ACXP Comparison

Compare INKT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • ACXP
  • Stock Information
  • Founded
  • INKT 2017
  • ACXP 2017
  • Country
  • INKT United States
  • ACXP United States
  • Employees
  • INKT N/A
  • ACXP N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • INKT Health Care
  • ACXP Health Care
  • Exchange
  • INKT Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • INKT 43.0M
  • ACXP 31.4M
  • IPO Year
  • INKT 2021
  • ACXP 2021
  • Fundamental
  • Price
  • INKT $10.82
  • ACXP $0.76
  • Analyst Decision
  • INKT Strong Buy
  • ACXP Strong Buy
  • Analyst Count
  • INKT 2
  • ACXP 1
  • Target Price
  • INKT $6.50
  • ACXP $12.00
  • AVG Volume (30 Days)
  • INKT 71.7K
  • ACXP 273.8K
  • Earning Date
  • INKT 03-20-2025
  • ACXP 03-14-2025
  • Dividend Yield
  • INKT N/A
  • ACXP N/A
  • EPS Growth
  • INKT N/A
  • ACXP N/A
  • EPS
  • INKT N/A
  • ACXP N/A
  • Revenue
  • INKT N/A
  • ACXP N/A
  • Revenue This Year
  • INKT N/A
  • ACXP N/A
  • Revenue Next Year
  • INKT N/A
  • ACXP N/A
  • P/E Ratio
  • INKT N/A
  • ACXP N/A
  • Revenue Growth
  • INKT N/A
  • ACXP N/A
  • 52 Week Low
  • INKT $4.56
  • ACXP $0.68
  • 52 Week High
  • INKT $19.00
  • ACXP $3.35
  • Technical
  • Relative Strength Index (RSI)
  • INKT 59.75
  • ACXP 44.22
  • Support Level
  • INKT $7.32
  • ACXP $0.75
  • Resistance Level
  • INKT $13.79
  • ACXP $0.82
  • Average True Range (ATR)
  • INKT 2.07
  • ACXP 0.05
  • MACD
  • INKT 0.28
  • ACXP 0.01
  • Stochastic Oscillator
  • INKT 71.94
  • ACXP 29.23

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Share on Social Networks: